Trials / Unknown
UnknownNCT03698812
A Multicenter Prospective Cohort Study on the Clinical Prognosis of Ulcerative Colitis
A Multicenter Prospective Follow-up Study on the Effect of Histological Remission on the Clinical Prognosis of Ulcerative Colitis
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 9 (estimated)
- Sponsor
- Nanfang Hospital, Southern Medical University · Academic / Other
- Sex
- All
- Age
- 14 Years – 75 Years
- Healthy volunteers
- Accepted
Summary
Mucosal healing or histological remission is an important target for the treatment of inflammatory bowel disease. In this study, patients with mucosal healing are defined as a control group, observing their clinical outcomes for 3 years, and describing the recurrence rate. The secondary objective is to study the operative rate, glucocorticoid utilization rate, treatment escalation rate, hospitalization rate and incidence of related complications.
Detailed description
Assess the health condition of patients for 1year, 2year,3year and analyze outcomes and complications.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| COMBINATION_PRODUCT | Colonoscope | take off specimen |
Timeline
- Start date
- 2017-01-01
- Primary completion
- 2020-09-30
- Completion
- 2021-09-30
- First posted
- 2018-10-09
- Last updated
- 2018-10-17
Locations
1 site across 1 country: China
Regulatory
- FDA-regulated drug study
- FDA-regulated device study
Source: ClinicalTrials.gov record NCT03698812. Inclusion in this directory is not an endorsement.